About SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
Gilead Sciences
2
Clinical Trials at SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung
During the past decade, SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on
average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)
A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer
A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)
According to Clinical.Site data, the most researched conditions in "SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung" are
"HIV" (2 trials), "HIV Infections" (2 trials), "Cancer" (1 trials), "NSCLC" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung" in a lesser frequency.
Most popular intervention types in "SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung" are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (4 trials), "Carboplatin" (3 trials), "Tiragolumab" (3 trials), "ATV" (2 trials) and "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (2 trials). Other intervention names were less common.
The vast majority of trials in "SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung" are
9 trials for "All" genders.
Clinical Trials Status at SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung
Currently, there are NaN active trials in "SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung".
undefined are not yet recruiting,
2 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".